ORAL ADMINISTRATION OF HYPERIMMUNE ANTI–CRYPTOSPORIDIUM PARVUM OVINE COLOSTRAL WHEY CONFERS A HIGH LEVEL OF PROTECTION AGAINST CRYPTOSPORIDIOSIS IN NEWBORN NMRI MICE

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of Parasitology

• Publication date

  2005-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1645/GE-3423PMID 16108564
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Efficacy of α-cyclodextrin against experimental cryptosporidiosis in neonatal goats

  2004cited by this paper
• Efficacy of alpha-cyclodextrin against experimental cryptosporidiosis in neonatal goats.

  2004cited by this paper
• A review of the importance of cryptosporidiosis in farm animals

  1999cited by this paper
• Protection of kids against Cryptosporidium parvum infection after immunization of dams with CP15-DNA.

  1999cited by this paper
• Protection of calves against cryptosporidiosis with immune bovine colostrum induced by a Cryptosporidium parvum recombinant protein.

  1999cited by this paper
• Hyperimmune bovine colostrum specific for recombinant Cryptosporidium parvum antigen confers partial protection against cryptosporidiosis in immunosuppressed adult mice.

  1999cited by this paper
• Antibody-based immunotherapy of cryptosporidiosis.

  1998influential reference
• Role of Immunoglobulin A Monoclonal Antibodies against P23 in Controlling Murine Cryptosporidium parvum Infection

  1998cited by this paper
• Innate and cell-mediated immune responses to Cryptosporidium parvum.

  1998cited by this paper
• Chemotherapy of human and animal coccidioses: state and perspectives

  1996cited by this paper
• Protection of calves with a vaccine against Cryptosporidium parvum.

  1995cited by this paper
• Cryptosporidium and cryptosporidiosis in man and animals.

  1995cited by this paper
• Attempts to protect severe combined immunodeficient (scid) mice with antibody enriched for reactivity to Cryptosporidium parvum surface antigen-1.

  1995cited by this paper
• Evaluation of an animal model system for cryptosporidiosis: therapeutic efficacy of paromomycin and hyperimmune bovine colostrum-immunoglobulin.

  1994cited by this paper
• Bovine antibody against Cryptosporidium parvum elicits a circumsporozoite precipitate-like reaction and has immunotherapeutic effect against persistent cryptosporidiosis in SCID mice

  1994cited by this paper
• Attachment of Cryptosporidium parvum sporozoites to MDCK cells in vitro

  1994cited by this paper
• Treatment of experimental ovine cryptosporidiosis with ovine or bovine hyperimmune colostrum.

  1994cited by this paper
• Anti-Cryptosporidium parvum antibodies inhibit infectivity in vitro and in vivo

  1993cited by this paper
• Neutralisation of Cryptosporidium parvum sporozoites by immunoglobulin and non-immunoglobulin components in serum.

  1993cited by this paper
• Anti-Cryptosporidium parvum antibodies inhibit infectivity in vitro and in vivo.

  1993cited by this paper
• Dose response of Cryptosporidium parvum in outbred neonatal CD-1 mice

  1993cited by this paper
• Enhancement of resistance to Cryptosporidium parvum by pooled bovine colostrum during murine retroviral infection.

  1993cited by this paper
• Characterization of a > 900,000-M(r) Cryptosporidium parvum sporozoite glycoprotein recognized by protective hyperimmune bovine colostral immunoglobulin

  1992cited by this paper
• In vitro screening of therapeutic agents against Cryptosporidium: hyperimmune cow colostrum is highly inhibitory.

  1991cited by this paper
• Molecular cloning of the cDNA encoding an immunodominant antigen of Dirofilaria immitis

  1991cited by this paper
• Identification of a 15-kilodalton surface glycoprotein on sporozoites of Cryptosporidium parvum

  1991cited by this paper
• Kinetics of Cryptosporidium parvum sporozoite neutralization by monoclonal antibodies, immune bovine serum, and immune bovine colostrum

  1990cited by this paper
• Cryptosporidium parvum (Apicomplexa: Cryptosporidiidae) oocyst and sporozoite antigens recognized by bovine colostral antibodies

  1990cited by this paper
• Immunotherapeutic efficacy of bovine colostral immunoglobulins from a hyperimmunized cow against cryptosporidiosis in neonatal mice

  1990cited by this paper
• Effects of colostral antibody on susceptibility of calves to Cryptosporidium parvum infection.

  1989cited by this paper
• Effect of disinfection of drinking water with ozone or chlorine dioxide on survival of Cryptosporidium parvum oocysts

  1989cited by this paper
• Effects of immune colostrum and orally administered antisporozoite monoclonal antibodies on the outcome of Cryptosporidium parvum infections in neonatal mice

  1989cited by this paper
• Isolation of Cryptosporidium oocysts and sporozoites using discontinuous sucrose and isopycnic Percoll gradients.

  1987influential reference
• Measurement of protein using bicinchoninic acid.

  1985cited by this paper

• Host innate immune responses and microbiome profile of neonatal calves challenged with Cryptosporidium parvum and the effect of bovine colostrum supplementation

  2023cites this paper
• Breast Milk: A Source of Functional Compounds with Potential Application in Nutrition and Therapy

  2021cites this paper
• Delivery of SA35 and SA40 peptides in mice enhances humoral and cellular immune responses and confers protection against Cryptosporidium parvum infection

  2019cites this paper
• Lessons Learned from Protective Immune Responses to Optimize Vaccines against Cryptosporidiosis

  2017cites this paper
• Vaccination against parasites – status quo and the way forward

  2016cites this paper
• Nutrition in Clinical Care Clinical applications of bioactive milk components

  2015cites this paper
• Clinical applications of bioactive milk components.

  2015cites this paper
• Prevalencia de Cryptosporidium spp. en alpacas (Vicugna pacos) machos reproductores del Centro Experimental La Raya, Cuzco

  2014cites this paper
• Transfer of Cystoisospora suis-specific colostral antibodies and their correlation with the course of neonatal porcine cystoisosporosis.

  2013cites this paper
• Cryptosporidiosis in patients with HIV/AIDS

  2011cites this paper
• Foodborne illness associated with Cryptosporidium and Giardia from livestock.

  2011cites this paper
• Bioactive components of milk

  2008cites this paper
• Targeted antibodies in dairy-based products.

  2008cites this paper
• Experimental study of the effects of probiotics on Cryptosporidium parvum infection in neonatal rats

  2006cites this paper